Tumour biology: Policing of oncogene activity by p53

Nature

Volumn 443, Issue 7108, 2006, Pages 159-

  Efeyan, Alejo ^a   Garcia Cao, Isabel ^a   Herranz, Daniel ^a   Velasco Miguel, Susana ^a   Serrano, Manuel ^a  

^a Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE;

BIOLOGY; GENE EXPRESSION; TUMOR;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CONTROLLED STUDY; DNA DAMAGE; GENE MUTATION; GENETIC ENGINEERING; GENETIC MANIPULATION; LYMPHOMA; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOMA; THYMOCYTE; TRANSGENICS; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 33748674375     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/443159a     Document Type: Article

References (10)

1. Harris, S. L. & Levine, A. J. Oncogene 24, 2899-2908 (2005).
2. Kamijo, T. et al. Cell 91, 649-659 (1997).
3. Garcia-Cao, I. et al. EMBO J. 21, 6225-6235 (2002).
4. Stott, F. J. et al. EMBO J. 17, 5001-5014 (1998).
5. Kamijo, T. et al. Cancer Res. 59, 2464-2469 (1999).
6. Palmero, I., Pantoja, C. & Serrano, M. Nature 395, 125-126 (1998).
7. Zindy, F. et al. Genes Dev. 12, 2424-2433 (1998).
8. de Stanchina, E. et al. Genes Dev. 12, 2434-2442 (1998).
9. Sharpless, N. E. Mutat. Res. 576, 22-38 (2005).
10. Bartek, J. & Lukas, J. Cancer Cell 3, 421-429 (2003).